Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia.
Cozzi-Lepri A, Borghi V, Rotundo S, Mariani B, Ferrari A, Del Borgo C, Bai F, Colletti P, Miraglia P, Torti C, Cattelan AM, Cenderello G, Berruti M, Tascini C, Parruti G, Coladonato S, Gori A, Marchetti G, Lichtner M, Coppola L, Sorace C, D'Abramo A, Mazzotta V, Guaraldi G, Franceschini E, Meschiari M, Sarmati L, Antinori A, Nicastri E, Mussini C. Cozzi-Lepri A, et al. Among authors: miraglia p. Front Med (Lausanne). 2024 Mar 11;11:1293431. doi: 10.3389/fmed.2024.1293431. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38529120 Free PMC article.
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology.
Radin M, Cecchi I, Barinotti A, Wilson Jones G, Arbrile M, Miraglia P, Mahler M, Bentow C, Rossi D, Menegatti E, Roccatello D, Sciascia S. Radin M, et al. Among authors: miraglia p. Autoimmun Rev. 2023 May;22(5):103298. doi: 10.1016/j.autrev.2023.103298. Epub 2023 Feb 14. Autoimmun Rev. 2023. PMID: 36796708 Review. No abstract available.
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination.
Ramirez GA, Argolini LM, Schioppo T, Sciascia S, Moroni L, Moroni G, Sinico RA, Bonelli G, Alberici F, Mescia F, Tamborini F, Miraglia P, Bellocchi C, Beretta L, Roccatello D, Bozzolo EP, Caporali R, Gerosa M, Dagna L; SMILE, Milan Lupus Consortium. Ramirez GA, et al. Among authors: miraglia p. Ann Rheum Dis. 2022 Aug 3:annrheumdis-2022-222832. doi: 10.1136/ard-2022-222832. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35922121 No abstract available.
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study.
Gerosa M, Schioppo T, Argolini LM, Sciascia S, Ramirez GA, Moroni G, Sinico RA, Bonelli G, Alberici F, Mescia F, Moroni L, Tamborini F, Miraglia P, Bellocchi C, Beretta L, Roccatello D, Dagna L, Bozzolo E, Caporali R. Gerosa M, et al. Among authors: miraglia p. Vaccines (Basel). 2022 Apr 22;10(5):663. doi: 10.3390/vaccines10050663. Vaccines (Basel). 2022. PMID: 35632419 Free PMC article.
Field-Portable Microplastic Sensing in Aqueous Environments: A Perspective on Emerging Techniques.
Blevins MG, Allen HL, Colson BC, Cook AM, Greenbaum AZ, Hemami SS, Hollmann J, Kim E, LaRocca AA, Markoski KA, Miraglia P, Mott VL, Robberson WM, Santos JA, Sprachman MM, Swierk P, Tate S, Witinski MF, Kratchman LB, Michel APM. Blevins MG, et al. Among authors: miraglia p. Sensors (Basel). 2021 May 19;21(10):3532. doi: 10.3390/s21103532. Sensors (Basel). 2021. PMID: 34069517 Free PMC article.
14 results